Here we utilized a triple-negative breast cancer cell line, MDA-MB-231, that forms dense hypoxic tumors in vivo to study the posttranslational regulation of BNIP3 in hypoxic and nonhypoxic conditions (Kim et al, 2018; Xie et al, 2016). Here, BNIP3 is linked to triple-negative breast carcinoma.